RIPK1‐mediated immunogenic cell death promotes anti‐tumour immunity against soft‐tissue sarcoma

Drugs that mobilise the immune system against cancer are dramatically improving care for many people. Dying cancer cells play an active role in inducing anti‐tumour immunity but not every form of death can elicit an immune response. Moreover, resistance to apoptosis is a major problem in cancer trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Henry G, Jamal, Kunzah, Dayal, Jasbani HS, Tenev, Tencho, Kyula‐Currie, Joan, Guppy, Naomi, Gazinska, Patrycja, Roulstone, Victoria, Liccardi, Gianmaria, Davies, Emma, Roxanis, Ioannis, Melcher, Alan A, Hayes, Andrew J, Inman, Gareth J, Harrington, Kevin J, Meier, Pascal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278545/
https://www.ncbi.nlm.nih.gov/pubmed/32419365
http://dx.doi.org/10.15252/emmm.201910979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278545/
https://www.ncbi.nlm.nih.gov/pubmed/32419365
http://dx.doi.org/10.15252/emmm.201910979

Ejemplares similares